Menu

Question 3001

Topic: Biology, Genetics & Bone Healing

A 5-year-old child presents with progressive varus bowing of the lower extremities, waddling gait, and short stature. Laboratory workup reveals normal serum calcium, markedly low serum phosphate, and elevated alkaline phosphatase. Genetic testing confirms X-linked hypophosphatemic rickets (XLH). The pathogenesis of this disorder is fundamentally driven by an excess of which circulating endocrine factor?

. Parathyroid hormone (PTH)
. 1,25-dihydroxyvitamin D
. Fibroblast growth factor-23 (FGF-23)
. Calcitonin
. Osteoprotegerin

Correct Answer & Explanation

. Fibroblast growth factor-23 (FGF-23)


Explanation

X-linked hypophosphatemic rickets (XLH) is the most common heritable form of rickets. It is caused by an inactivating mutation in the PHEX gene. Normally, PHEX degrades fibroblast growth factor-23 (FGF-23). The mutation leads to unchecked, elevated levels of FGF-23, which acts potently on the kidneys to downregulate sodium-phosphate cotransporters (causing severe renal phosphate wasting) and inhibits 1-alpha-hydroxylase (reducing active Vitamin D formation).

Question 3002

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, primary (direct) bone healing without callus formation occurs under conditions of absolute stability. What is the maximum allowable interfragmentary strain that permits primary bone healing to occur via cutting cones?

. Less than 2%
. 2% to 10%
. 10% to 30%
. 30% to 50%
. Greater than 50%

Correct Answer & Explanation

. Less than 2%


Explanation

Perren's strain theory states that the type of tissue that forms between fracture fragments depends on interfragmentary strain. Primary (direct) bone healing via Haversian remodeling (cutting cones) requires absolute stability, meaning the strain must be less than 2%. Strains between 2% and 10% result in secondary bone healing with callus formation.

Question 3003

Topic: Biology, Genetics & Bone Healing

A 72-year-old female presents with progressive groin pain 10 years after a total hip arthroplasty. Radiographs show eccentric wear of the polyethylene liner and massive periprosthetic osteolysis. The biological cascade leading to this osteolysis is primarily mediated by macrophages phagocytosing wear debris. Which molecule is ultimately secreted to activate osteoclasts and drive bone resorption in this process?

. Interleukin-10 (IL-10)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Transforming growth factor-beta (TGF-beta)
. Osteoprotegerin (OPG)
. Bone morphogenetic protein-2 (BMP-2)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

Particle-induced osteolysis is driven by macrophages that phagocytose polyethylene wear debris and release pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6). These cytokines stimulate osteoblasts and fibroblasts to upregulate RANKL. RANKL binds to RANK receptors on osteoclast precursors, leading to osteoclast differentiation and massive bone resorption (osteolysis). OPG acts as a decoy receptor to inhibit this process.

Question 3004

Topic: Biology, Genetics & Bone Healing

A 28-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic, 'soap-bubble' lesion in the epiphysis of the distal femur extending to the subchondral bone. Biopsy shows mononuclear cells and numerous multinucleated giant cells. The neoplastic cells in this tumor are known to express high levels of which surface marker, providing a target for medical therapy with Denosumab?

. CD99
. RANKL
. Vimentin
. S-100
. Estrogen receptor

Correct Answer & Explanation

. RANKL


Explanation

The clinical and histologic description is diagnostic of a Giant Cell Tumor (GCT) of bone. The true neoplastic cells in GCT are the spindle-shaped mononuclear stromal cells, which express high levels of RANKL. This RANKL over-expression recruits and activates normal multinucleated osteoclast-like giant cells, leading to massive bone destruction. Denosumab, a monoclonal antibody against RANKL, is an effective medical treatment for inoperable or recurrent GCTs.

Question 3005

Topic: Biology, Genetics & Bone Healing

Denosumab is an effective targeted medical therapy utilized in the management of unresectable or metastatic giant cell tumors of bone (GCTB). What is the specific mechanism of action of Denosumab in this disease?

. Inhibition of vascular endothelial growth factor (VEGF)
. Inhibition of the mammalian target of rapamycin (mTOR) pathway
. Monoclonal antibody against RANKL, preventing osteoclast activation
. Direct cytotoxicity to the neoplastic mononuclear cells
. Inhibition of tyrosine kinase receptors

Correct Answer & Explanation

. Monoclonal antibody against RANKL, preventing osteoclast activation


Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). In Giant Cell Tumor of Bone, the neoplastic mononuclear stroma cells secrete RANKL, which aggressively recruits and activates the multinucleated giant cells (osteoclast-like cells) that cause bone destruction. Denosumab binds RANKL, effectively halting this destructive process.

Question 3006

Topic: Biology, Genetics & Bone Healing
During secondary bone healing, endochondral ossification is responsible for the formation of the fracture soft callus. Which type of collagen is predominantly synthesized by the cells within this soft callus?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen


Explanation

The soft callus in endochondral fracture healing is primarily composed of cartilage, which is produced by proliferating chondrocytes. The extracellular matrix of cartilage is predominantly composed of Type II collagen. As healing progresses to the hard callus phase, osteoblasts deposit woven bone, which is predominantly composed of Type I collagen.

Question 3007

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in bone healing and remodeling. Upon BMP binding to its cell surface receptor, which intracellular signaling pathway is primarily activated to stimulate osteoblast differentiation?

. Wnt/beta-catenin
. JAK/STAT
. Smad 1/5/8
. MAPK/ERK
. Notch/Hes

Correct Answer & Explanation

. Smad 1/5/8


Explanation

BMPs signal primarily through the canonical Smad pathway, specifically phosphorylating Smads 1, 5, and 8. These complex with Smad 4 to translocate into the nucleus and upregulate osteogenic genes like Runx2.

Question 3008

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory, absolute stability (strain less than 2%) is required to promote which type of bone healing?

. Primary bone healing via Haversian remodeling
. Secondary bone healing via endochondral ossification
. Secondary bone healing via intramembranous ossification
. Callus formation and maturation
. Woven bone bridging

Correct Answer & Explanation

. Primary bone healing via Haversian remodeling


Explanation

Primary bone healing (contact healing) requires absolute stability with strain below 2%, allowing osteoclasts to form cutting cones followed by osteoblasts laying down new osteons. Secondary bone healing involves callus formation and tolerates higher strain.

Question 3009

Topic: Biology, Genetics & Bone Healing

A 65-year-old female with severe osteoporosis and a recent distal radius fracture is started on denosumab. Which of the following accurately describes the mechanism of action of this medication?

. It mimics pyrophosphate and binds to hydroxyapatite crystals
. It is a monoclonal antibody that binds to and inhibits RANKL
. It directly stimulates osteoblasts by activating the Wnt pathway
. It is a selective estrogen receptor modulator
. It inhibits the enzyme cathepsin K in osteoclasts

Correct Answer & Explanation

. It is a monoclonal antibody that binds to and inhibits RANKL


Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL). This prevents RANKL from activating RANK on osteoclasts, thereby inhibiting bone resorption.

Question 3010

Topic: Biology, Genetics & Bone Healing

A 72-year-old female on chronic alendronate therapy presents with groin pain and sustains a low-energy subtrochanteric femur fracture. X-rays show a transverse fracture with lateral cortical thickening and a medial spike. What is the fundamental mechanism driving this specific fracture pattern?

. Severe hyperparathyroidism
. Suppression of targeted bone remodeling and microdamage accumulation
. Increased osteoclast activity leading to localized osteolysis
. Vitamin D deficiency causing osteomalacia
. Stress shielding from a previous undetected implant

Correct Answer & Explanation

. Suppression of targeted bone remodeling and microdamage accumulation


Explanation

Atypical femur fractures in patients on long-term bisphosphonates are caused by severe suppression of bone turnover. This prevents the normal remodeling and repair of physiologic microdamage, leading to stress fractures typically in the subtrochanteric region.

Question 3011

Topic: Biology, Genetics & Bone Healing

Articular cartilage is highly resilient due to its specialized extracellular matrix. Which of the following represents the most abundant solid component of the articular cartilage matrix by dry weight?

. Aggrecan
. Chondroitin sulfate
. Type I collagen
. Type II collagen
. Hyaluronic acid

Correct Answer & Explanation

. Type II collagen


Explanation

While water is the most abundant component by wet weight, Type II collagen is the most abundant solid macromolecule by dry weight (approx. 60%). Proteoglycans like aggrecan make up the second largest solid component.

Question 3012

Topic: Biology, Genetics & Bone Healing

Recombinant human parathyroid hormone (Teriparatide) is used for the treatment of severe osteoporosis. While continuous high levels of PTH cause bone resorption, how does intermittent daily administration of teriparatide primarily affect bone?

. It inhibits osteoclast formation by blocking RANKL
. It directly stimulates osteoclast apoptosis
. It exerts an anabolic effect by stimulating osteoblast proliferation and inhibiting osteoblast apoptosis
. It binds to hydroxyapatite and prevents dissolution
. It decreases renal calcium reabsorption

Correct Answer & Explanation

. It exerts an anabolic effect by stimulating osteoblast proliferation and inhibiting osteoblast apoptosis


Explanation

Intermittent, low-dose administration of PTH (teriparatide) has a profound anabolic effect on bone. It preferentially stimulates osteoblastic bone formation by increasing osteoblast number, promoting their maturation, and preventing their apoptosis.

Question 3013

Topic: Biology, Genetics & Bone Healing

A 76-year-old female with osteoporosis suffers a T12 compression fracture. She has been treated conservatively with bracing, analgesics, and activity modification. Six weeks later, she still requires narcotic pain medication to ambulate. MRI is ordered to evaluate for percutaneous vertebroplasty. Which MRI sequence finding most strongly correlates with successful pain relief following vertebroplasty?

. A fluid cleft on T1-weighted images
. Loss of vertebral height >75% on sagittal CT
. Hyperintensity (edema) within the fractured vertebral body on STIR or T2-weighted images
. Hypointensity of the adjacent discs on T2-weighted images
. Tethering of the conus medullaris

Correct Answer & Explanation

. Hyperintensity (edema) within the fractured vertebral body on STIR or T2-weighted images


Explanation

The presence of bone marrow edema (hyperintensity) on Short Tau Inversion Recovery (STIR) or T2-weighted MRI indicates an acute or subacute, non-healed fracture. This finding strongly correlates with a favorable clinical outcome (pain relief) following cement augmentation procedures like vertebroplasty or kyphoplasty. Conversely, if the vertebral body shows no edema, the fracture is considered healed, and vertebroplasty will not relieve the patient's mechanical back pain.

Question 3014

Topic: Biology, Genetics & Bone Healing

A 32-year-old female undergoes curettage and cementing of a giant cell tumor of the proximal tibia. Recurrence occurs 18 months later, with massive joint destruction precluding joint salvage. Neoadjuvant treatment is planned prior to an intra-articular resection. What is the mechanism of action of the targeted medical therapy typically used in this scenario?

. Inhibition of the tyrosine kinase pathway via imatinib.
. Direct binding to the RANK receptor on osteoclast precursors.
. Binding to RANK-Ligand (RANKL), preventing its interaction with the RANK receptor.
. Inhibition of the vascular endothelial growth factor (VEGF) pathway.
. Cross-linking of DNA leading to apoptosis of the neoplastic stromal cells.

Correct Answer & Explanation

. Binding to RANK-Ligand (RANKL), preventing its interaction with the RANK receptor.


Explanation

Denosumab is a fully human monoclonal antibody that binds to RANK-Ligand (RANKL), preventing it from binding to the RANK receptor on the surface of osteoclast precursors. In Giant Cell Tumor of Bone (GCTB), the neoplastic mononuclear stromal cells overexpress RANKL, which recruits and activates the reactive multinucleated giant cells that cause massive osteolysis. By inhibiting RANKL, denosumab halts bone destruction and promotes ossification of the tumor.

Question 3015

Topic: Biology, Genetics & Bone Healing

A 68-year-old female presents with severe back pain. Radiographs show multiple 'punched-out' lytic lesions in the skull and vertebral bodies. Laboratory testing reveals hypercalcemia and an M-spike on serum protein electrophoresis. The extensive osteolysis in this disease is primarily mediated by the interaction between myeloma cells and the bone microenvironment. Which specific mechanism is responsible for osteoclast overactivation in this condition?

. Overexpression of Osteoprotegerin (OPG) by myeloma cells
. Direct physical destruction of trabeculae by expanding plasma cell clones
. Myeloma cell secretion of MIP-1 alpha, leading to upregulation of RANKL
. Inhibition of the Wnt/beta-catenin pathway by sclerostin secreted directly by plasma cells
. Stimulation of osteoclastogenesis via parathyroid hormone-related peptide (PTHrP)

Correct Answer & Explanation

. Myeloma cell secretion of MIP-1 alpha, leading to upregulation of RANKL


Explanation

In Multiple Myeloma, the myeloma cells secrete macrophage inflammatory protein-1 alpha (MIP-1 alpha) and upregulate RANK-Ligand (RANKL) expression by marrow stromal cells, while simultaneously decreasing Osteoprotegerin (OPG). This creates a high RANKL/OPG ratio, shifting the balance heavily toward osteoclastogenesis and causing extensive lytic lesions. Bone formation is also suppressed via DKK-1 inhibition of the Wnt pathway.

Question 3016

Topic: Biology, Genetics & Bone Healing

A 70-year-old male with a history of advanced prostate cancer presents with severe low back pain. Radiographs demonstrate widespread blastic metastases in the lumbar spine and pelvis. The osteoblastic nature of prostate cancer bone metastases is primarily driven by the secretion of which of the following factors by the tumor cells?

. Macrophage inflammatory protein-1 alpha (MIP-1 alpha)
. Parathyroid hormone-related peptide (PTHrP)
. Endothelin-1 (ET-1)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Tumor necrosis factor alpha (TNF-alpha)

Correct Answer & Explanation

. Endothelin-1 (ET-1)


Explanation

Prostate cancer uniquely causes predominantly osteoblastic (bone-forming) metastases. Prostate cancer cells secrete Endothelin-1 (ET-1), which strongly stimulates osteoblast proliferation and new bone formation, while concurrently suppressing osteoclast activity. This heavily contrasts with breast and lung cancers, which typically secrete PTHrP, promoting RANKL expression and causing osteolytic lesions.

Question 3017

Topic: Biology, Genetics & Bone Healing

A patient with an unresectable sacral giant cell tumor of bone (GCTB) is treated with denosumab. Denosumab exerts its therapeutic effect in this condition by binding to which of the following?

. RANK receptor on osteoclast precursors
. RANKL secreted by neoplastic stromal cells
. Osteoprotegerin (OPG)
. Macrophage colony-stimulating factor (M-CSF)
. Vascular endothelial growth factor (VEGF)

Correct Answer & Explanation

. RANKL secreted by neoplastic stromal cells


Explanation

In GCTB, the neoplastic mononuclear stromal cells secrete RANKL, which recruits and activates normal osteoclast-like giant cells causing bone destruction. Denosumab is a monoclonal antibody that binds directly to RANKL, preventing this interaction.

Question 3018

Topic: Biology, Genetics & Bone Healing

A 65-year-old man presents with severe back pain and multiple lytic lesions in the axial skeleton on plain films. A technetium-99m bone scan shows no increased radiotracer uptake in these areas. What is the primary cellular mechanism driving bone destruction in this condition?

. Direct mechanical osteolysis by expanding tumor cells
. Increased OPG production by osteoblasts
. Upregulation of RANKL leading to osteoclast activation
. Uncoupled osteoblast hyperstimulation
. Defective osteoid mineralization by neoplastic plasma cells

Correct Answer & Explanation

. Upregulation of RANKL leading to osteoclast activation


Explanation

This patient has multiple myeloma, characterized by 'cold' lesions on a bone scan due to a lack of osteoblastic bone formation. Myeloma cells upregulate RANKL and downregulate OPG, leading to severe osteoclast activation and pure lytic bone destruction.

Question 3019

Topic: Biology, Genetics & Bone Healing
A 12-year-old girl is evaluated for a varus deformity of the proximal femur. Radiographs reveal a ground-glass appearance of the medullary canal. She also has unilateral café-au-lait spots with irregular borders. A mutation causing constitutive activation of the Gs-alpha protein (GNAS) is identified. What is the underlying histologic consequence of this mutation?
. Defective bone mineralization due to phosphate wasting
. Failure of normal woven bone to mature into lamellar bone
. Excessive osteoclastic resorption driven by RANKL overexpression
. Abnormal proliferation of malignant spindle cells in a myxoid stroma
. Defective heparan sulfate synthesis disrupting the growth plate

Correct Answer & Explanation

. Failure of normal woven bone to mature into lamellar bone


Explanation

Fibrous dysplasia, part of McCune-Albright syndrome when combined with endocrinopathies and café-au-lait spots, is caused by a GNAS mutation. This increases intracellular cAMP, impairing osteoblast differentiation and preventing the maturation of woven bone into lamellar bone.

Question 3020

Topic: Biology, Genetics & Bone Healing
Following arthroscopic rotator cuff repair, tendon-to-bone healing progresses through inflammatory, proliferative, and remodeling phases. During the early proliferative phase (weeks 2 to 4), what type of collagen is predominately synthesized by fibroblasts at the repair site?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type III collagen


Explanation

Tendon-to-bone healing initially involves the deposition of fibrovascular granulation tissue. During the proliferative phase (starting around week 1 and peaking at 3-4 weeks), fibroblasts primarily synthesize Type III collagen, which forms mechanically inferior, disorganized scar tissue. During the subsequent remodeling phase, this is gradually replaced by the stronger, more organized Type I collagen.